A pharmaceutical dosage form comprising 6 '- fluoro - (N - methyl - n, N - dimethyl - 2 - phenyl) - 4, 4' - phenyl Dihydro 3, 9 '-' H - 1,1 '- ciclohexan Spiro pyrano 3,4 - 4, b indole amine

摘要

Referring to a pharmaceutical dosage form for oral administration comprising a polymeric Matrix material which is dispersed in the Solid Active Agent of formula (i), wherein R is H or CH3 and the polymer is Copolymer of vinylpyrrolidone - polyvinylpyrrolidone, Polyvinyl Acetate, Cellulose Derivatives, among others.Also includes a Surfactant selected from polyoxyethylene Fatty Acid esters, esters of Fatty Acid esters and partial polioxietilensorbitan sulfuric acid.Favorites: compounds are (1R, 4R) - 6 '- fluoro - n, N - dimethyl - 2 - phenyl - 4' 9 ', 3' - dihydro - H - [1,1 '- ciclohexan Spiro pyrano [3,4] - 4, b] indole Amine, (1R, 4R) - 6' - fluoro - N - methyl - 4 - phenyl - 4 '9', 3 '- dihydro - H - [1,1' - ciclohexan Spiro pyrano [3,4] - 4, b] indole Amine or a Salt thereof. The dosage form is useful in the treatment of acute pain, Chronic neuropathic and visceral